GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS
Report
- Report Number
- 2017233-2024-05277
- Event Type
- Injury
- Date Received
- September 3, 2024
- Date of Event
- July 8, 2024
- Report Date
- October 3, 2024
- Manufacturer
- W. L. GORE & ASSOCIATES, INC.
- Product Code
- QZK
- UDI-DI
- 00733132659685
- PMA / PMN Number
- P230023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
H6: CODE B20 -THE DEVICE REMAINS IMPLANTED AND WAS THEREFORE NOT AVAILABLE FOR ENGINEERING EVALUATION BY GORE. W. L. GORE & ASSOCIATES, INC. (GORE) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY GORE, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. BLANK FIELDS PRESENT ON THIS REPORT INCLUDE REQUIRED FIELDS AND FIELDS DETERMINED TO BE NOT APPLICABLE. BLANK REQUIRED FIELDS INDICATE THAT THE INFORMATION WAS NOT PROVIDED, WAS DEEMED UNAVAILABLE OR WAS NOT APPLICABLE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, GORE, OR ITS ASSOCIATES THAT THE DEVICE, GORE OR ITS ASSOCIATES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE A LEGAL ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED, AS DEFINED FROM A LEGAL STANDPOINT. THESE WORDS ARE INCLUDED IN THE REPORT AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
ADDED B7, G3/G4, H1/H2, H6. H6: CODE C19: A REVIEW OF THE MANUFACTURING RECORDS INDICATED THE LOT MET ALL PRE-RELEASE SPECIFICATIONS. ACCORDING TO THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU), POSSIBLE ADVERSE EVENTS AND COMPLICATIONS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE BUT ARE NOT LIMITED TO RENAL COMPLICATIONS (ARTERY OCCLUSION AND FAILURE) AND OCCLUSION OF DEVICE OR NATIVE VESSEL.
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2024, THE PATIENT UNDERWENT AN ENDOVASCULAR TAMBE PROCEDURE IN ZONE 5 DESCENDING AORTA TO TREAT A JUXTARENAL ANEURYSM UTILIZING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS. AS BRANCH DEVICES, GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS WERE IMPLANTED IN THE VISCERAL ARTERIES. TWO VBX DEVICES WERE IMPLANTED (OVERLAPPED) IN THE LEFT RENAL ARTERY. ON (B)(6) 2024, THE FIELD SALES ASSOCIATE (FSA) WAS NOTIFIED BY THE PHYSICIAN THAT THE LEFT RENAL PORTAL OF TAMBE DEVICE HAS THROMBOSED ALONG WITH THE TWO GORES® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS AND LEADING TO THE OCCLUSION OF THE PATIENT'S LEFT RENAL ARTERY. REPORTEDLY, THIS WAS A KNOWN PROBABILITY DUE TO THE ANATOMY OF THE ANEURYSM AS PATIENT'S ANATOMY WAS CHALLENGING AND TORTUROUS. THE OCCLUSION WAS FOUND DURING A POST-OP CT SCAN THAT WAS DONE PRIOR TO DISCHARGE FROM HOSPITALIZATION (DATE UNKNOWN). THE PHYSICIAN IS GOING TO GET A FOLLOW UP CT SCAN DONE IN 6 MONTHS. NO INTERVENTION IS PLANNED AT THIS TIME AND PATIENT IS DOING FINE BUT HAS LOST LEFT KIDNEY FUNCTION. NO DIALYSIS APPEARS TO BE NEEDED AT THIS TIME.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1186601 | GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS | ENDOVASCULAR SYSTEM FOR TREATMENT OF THORACOABDOMINAL AND PARARENAL AORTIC LESIO | QZK | W. L. GORE & ASSOCIATES, INC. | 00733132659685 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR | Female | Other| H| R |